SUPREME MEDICAL LABORATORIES LLC
NPI 1619488418
Clinical Medical Laboratory in Frisco, TX
NPI Status: Active since October 19, 2017
Contact Information
3803 PARKWOOD BLVD STE 400
FRISCO, TX
ZIP 75034
Phone: (469) 850-0548
Fax: (469) 850-0547
- Organization
- Clinical Medical Laboratory
- Accepts Insurance
- CLIA Number: 04D2312315
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 10-08-2026
About SUPREME MEDICAL LABORATORIES LLC
This page provides the complete NPI Profile along with additional information for Supreme Medical Laboratories Llc, a provider established in Frisco, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1619488418 assigned on October 2017. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated May 2025. The provider's
- NPI
- 1619488418
- Provider Legal Name
- SUPREME MEDICAL LABORATORIES LLC
- Other Organization Name
- Other Name Type
- (6)
- Entity Type
- Organization
- Location Address
- 3803 PARKWOOD BLVD STE 400 FRISCO, TX 75034
- Location Phone
- (469) 850-0548
- Location Fax
- (469) 850-0547
- Mailing Address
- 3803 PARKWOOD BLVD STE 400 FRISCO, TX 75034
- Mailing Phone
- (469) 850-0548
- Mailing Fax
- (469) 850-0547
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 10-19-2017
- Last Update Date
- 05-21-2025
- Code Navigator
Establishments like Supreme Medical Laboratories Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Secondary Locations
- 2 Innwood Cir Ste C
Little Rock, AR 72211
(469) 782-8928 - 12410 Cantrell Rd Ste 101
Little Rock, AR 72223
(469) 782-8928
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
- Blue Advantage Bronze HMO? 204 - HMO
- Blue Advantage Bronze HMO? 301 - HMO
- Blue Advantage Bronze HMO? Standard - HMO
- Blue Advantage Gold HMO? 206 - HMO
- Blue Advantage Gold HMO? 603 - HMO
- Blue Advantage Gold HMO? Standard - HMO
- Blue Advantage Plus Bronze? 303 - POS
- Blue Advantage Plus Bronze? 305 - POS
- Blue Advantage Plus Bronze? Standard - POS
- Blue Advantage Plus Gold? 203 - POS
- Blue Advantage Plus Gold? 803 - POS
- Blue Advantage Plus Gold? Standard - POS
- Blue Advantage Plus Silver? 202 - POS
- Blue Advantage Plus Silver? 605 - POS
- Blue Advantage Plus Silver? Standard - POS
- Blue Advantage Security HMO? 200 - HMO
- Blue Advantage Silver HMO? 205 - HMO
- Blue Advantage Silver HMO? 801 - HMO
- Blue Advantage Silver HMO? Standard - HMO
- Gold 1 - HMO
- Gold 1 with Adult Vision Services - HMO
- Gold 12 - HMO
- Gold 8 - HMO
- Silver 1 - HMO
- Silver 1 with Adult Vision Services - HMO
- Silver 12 with First 4 Primary Care Visits Free - HMO
- Silver 8 - HMO
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Detection of mycoplasma genitalium by dna or rna probe
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
Detection test for candida species (yeast), amplified probe technique
Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants
Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants
Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants
Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants
Identification of organisms by genetic analysis, amplified probe technique
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Testing for presence of drug, by chemistry analyzers
This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.
This service was performed 37 times for 32 patientsThis is a test that identifies various microorganisms in your body using a method called amplified probe technique. It targets specific genetic material (nucleic acids) of the organisms, amplifying them for easy detection. This helps in diagnosing infections accurately.
This service was performed 528 times for 161 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 2,509 times for 179 patientsA detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.
This service was performed 182 times for 162 patientsA detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.
This service was performed 70 times for 67 patientsThis test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.
This service was performed 88 times for 86 patientsA detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.
This service was performed 159 times for 145 patientsThe detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.
This service was performed 180 times for 160 patientsThis test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
This service was performed 375 times for 163 patientsGene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.
This service was performed 85 times for 85 patientsGene analysis of cytochrome P450 2C19 common variants is a test that helps understand how your body processes certain medications. This can help your doctor tailor treatments specifically for you, improving their effectiveness and safety.
This service was performed 59 times for 59 patientsGene analysis for cytochrome P450 2C9 common variants is a test to identify specific genetic variations. These variations can affect how your body processes certain medications, helping to determine the most effective and safe drug dosage for you.
This service was performed 25 times for 25 patientsGene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.
This service was performed 61 times for 61 patientsThis procedure involves identifying organisms like bacteria or viruses in your body. It's done by amplifying a small part of their genetic material, making it easier to detect. This technique helps in accurate diagnosis and appropriate treatment.
This service was performed 1,254 times for 111 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 1,685 times for 292 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 1,700 times for 292 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 897 times for 153 patientsChemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.
This service was performed 17 times for 14 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 04D2312315
- Facility Type
- Independent
- Certificate Effective Date
- October 09, 2024
- Certificate Expiration Date
- October 08, 2026
- Laboratory Director
- DR. KARI K. HOOPER
- Certificate Type
- Certificate of Accreditation
- Certificate Type Description
- This is a CLIA certificate is issued to Supreme Medical Laboratories Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.
Reviews for SUPREME MEDICAL LABORATORIES LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI Validation Check Digit Calculation
The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.
| Start with the original NPI number, the last digit is the check digit and is not used in the calculation. | |||||||||
| 1 | 6 | 1 | 9 | 4 | 8 | 8 | 4 | 1 | 8 |
| Step 1: Double the value of the alternate digits, beginning with the rightmost digit. | |||||||||
| 2 | 6 | 2 | 9 | 8 | 8 | 16 | 4 | 2 | |
| Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24. | |||||||||
| 2 + 6 + 2 + 9 + 8 + 8 + 1 + 6 + 4 + 2 + 24 = 72 | |||||||||
| Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit. | |||||||||
| 80 - 72 = 8 | 8 | ||||||||
The NPI number 1619488418 is valid because the calculated check digit 8 using the Luhn validation algorithm matches the last digit of the original NPI number.
Other Providers at the Same Location
The following provider is registered at the same or nearby location.
| NPI | Name / Type | Taxonomy | Address |
|---|---|---|---|
| 1619376316 | TRUE HEALTH DIAGNOSTICS, LLC Organization | Clinical Medical Laboratory | 3803 PARKWOOD BLVD STE 400 FRISCO, TX 75034 (972) 987-1390 |
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1619488418, enumerated in the NPI registry as an "organization" on October 19, 2017
The provider is located at 3803 Parkwood Blvd Ste 400 Frisco, Tx 75034 and the phone number is (469) 850-0548
This medical organization specializes in Clinical Medical Laboratory with taxonomy code 291U00000X
The provider might be accepting Accepts: Blue Cross and Blue Shield of Texas and Molina. Please consult your insurance carrier or call the provider to make sure your health plan is currently accepted.
The most common procedures or services performed by this practitioner are: Detection of mycoplasma genitalium by dna or rna probe, Detection test by nucleic acid for multiple organisms, amplified probe(s) technique, Detection test by nucleic acid for organism, amplified probe technique, Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique, Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique, Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique, Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique, Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique, Detection test for candida species (yeast), amplified probe technique, Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants, Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants, Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants, Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants, Identification of organisms by genetic analysis, amplified probe technique, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source and Testing for presence of drug, by chemistry analyzers.
The provider's CLIA number is 04D2312315 for a "independent" facility with a CLIA Certificate of Accreditation. This is a CLIA certificate is issued on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing..
This NPI record was last updated on October 19, 2017. To officially update your NPI information contact the National Plan and Provider Enumeration System (NPPES) at 1-800-465-3203 (NPI Toll-Free) or by email at [email protected].
NPI Profile data is regularly updated with the latest NPI registry information, if you would like to update or remove your NPI Profile in this website please contact us.